Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prima MediPharm is a South Korean pharmaceutical company focused on the development, manufacturing, and distribution of a wide range of therapeutic products. Established in 2006, the company specializes in finished dosage forms across various therapeutic areas, including respiratory, gastrointestinal, cardiovascular, and anti-infective treatments. Prima MediPharm operates modern, GMP-certified manufacturing facilities and provides both branded and generic medications to the domestic and international markets. Their business model emphasizes quality control and the expansion of their product portfolio through internal R&D and strategic partnerships. The company is a significant provider of essential medicines to hospitals and clinics within South Korea.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prima MediPharm.